🚀Exciting News - Our #CEO and president, Panna Sharma will be joining us on June 26th, 1PM Eastern time for a #webinar - STAR-001 in multiple brain and CNS cancers - to lead the live Q&A session. Register now bit.ly/3Rsce4W $LTRN

💡Did you know - 98% of cancer drugs do not cross the Blood Brain Barrier - which makes treating CNS cancers extremely challenging. Register now to learn more about the challenges in #braincancers and how Starlight Therapeutics is making a difference. bit.ly/3Rsce4W

Happening TOMORROW, June 26th, 1PM Eastern Time - Register now for a Webinar - STAR-001 in Multiple CNS and Brain Cancers, featuring Dr. Marc Chamberlain, CMO of Starlight Therapeutics and Panna Sharma, CEO and President of Lantern Pharma. $LTRN bit.ly/3Rsce4W

📣HAPPENING TODAY 📣 Register NOW to join us at 1PM Eastern, June 26th, for the Lantern Pharma #Webinar Wednesday - STAR-001 in multiple brain and CNS cancers. bit.ly/4bZEkg7 #Braincancerawareness

💡In case you missed it - Lantern Pharma #Webinar Wednesday - STAR-001 in Multiple Brain and CNS Cancers is now available on Lantern Pharma 's #Youtube Channel! youtu.be/aK8A6NkJI-8 $LTRN

Check out our CEO & president Panna Sharma on #TodayinNashville WSMV 4 Nashville with Carole Sullivan. Panna shares how Lantern Pharma is at the forefront of #AI in drug development, leveraging AI to develop cancer drugs faster and more cost-effectively. bit.ly/4eX1uWC $LTRN

Lantern Pharma announced a key milestone towards development of molecular diagnostic for use in oncology clinical trials for patient selection and stratification with drug candidate LP-184. $LTRN Read the full release here bit.ly/463q1oH

🖥️Happening TOMORROW, July 31st, 1PM Eastern time - Register now to join us for Lantern Pharma Webinar Wednesday "Starlight Therapeutics - born from AI, lighting the way in CNS cancer treatment" featuring our CEO and President, Panna Sharma, LIVE 📢 bit.ly/3WiYhIb

🖥️Happening TODAY, July 31st, 1PM Eastern time - Register now to join us for Lantern Pharma Webinar Wednesday "Starlight Therapeutics - born from AI, lighting the way in CNS cancer treatment" featuring our CEO and President, Panna Sharma, LIVE 📷 bit.ly/3WiYhIb

🗓️Save the date - August 8th, Thursday, 4:30PM Eastern Time, for our 2024 Second Quarter Operating & Financial Results Webinar. Register here bit.ly/3ymYbaC to join us as we share Lantern Pharma's updates and discuss future milestones! $LTRN

Happening TODAY, August 8th, 4:30PM(ET) - Register now for our 2024 Q2 financial & operating results call. Join us as we share our updates with additional focus on preliminary patient data and clinical readouts for Phase 2 LP-300 Harmonic Trial bit.ly/3ymYbaC. $LTRN

🎉 Congratulations to our collaborator, Actuate Therapeutics, Inc., on their IPO today! We look forward to continuing our multi-year research and development collaboration as we push the boundaries of what AI and precision medicine can achieve together. $LTRN $ACTU

Discover Lantern Pharma's Transformative AI-driven Cancer Therapy Development - $LTRN $ACTU $NVDA vistapglobal.com/lantern-pharma… Lantern Pharma Vk NVIDIA AI C3 AI Apple Microsoft #biotech Elon Musk Bill Gates #oncology #cancer #collaborations #partnerships #investing

🗓️Save the date - August 28th, 1PM ET for Lantern Pharma Webinar Wednesday- Harmonic™ Phase 2 Clinical Trial for Never Smokers with NSCLC- Preliminary patient data and clinical readouts - featuring Dr. Reggie Ewesuedo of Lantern Pharma Register Now bit.ly/3yVQ84N $LTRN

📢"...and clearly, we are really pleased with the safety profile we observed" Join us this Wednesday, August 28th, 1PM ET - for a webinar- Harmonic™ Trial for Never Smokers with NSCLC- Preliminary patient data and clinical readouts to learn more. bit.ly/3yVQ84N $LTRN

🖥️Happening TOMORROW, August 28th, Wednesday, 1PM Eastern - Join us for August Lantern Pharma Webinar Wednesday - Harmonic™ Phase 2 Clinical Trial for Never Smokers with NSCLC - Preliminary patient data and clinical readouts. Register now bit.ly/3AsS2dI $LTRN

💫HAPPENING TODAY! 💫Don't miss your chance to join the webinar - the Harmonic Trial preliminary data readout with Dr. Reggie Ewesuedo at 1PM ET Today. We will have a 10-minute webinar followed by a live Q&A session with Dr Ewesuedo. Register now bit.ly/3yVQ84N $LTRN

📢New Poster alert! @Lanternpharma's scientist, Jianli Zhou, Ph.D., shared some of the innovative work powered by our AI platform RADR® at #Soho2024. Check out the poster to learn more about Phase 1 #clinicaltrial for LP-284 in Non-Hodgkin Lymphomas. bit.ly/3yIRBLW $LTRN

Innovating Health Podcast of Health Wildcatters "Founder Story: Navigating the Path to Exit," is now live! Dr. Hubert Zajicek sits down with our President and CEO, Panna Sharma, to discuss his remarkable journey at the helm of Lantern Pharma 🎧Tune in now bit.ly/4gd6erP $LTRN

📢 New blog alert! Check out this article by DrugBank featuring Lantern Pharma’s innovative use of AI in oncology drug development. $LTRN 👉 Read it here: bit.ly/3MMyLHd